To our best knowledge, no studies have been conducted to understand the carcinogenic role and prognostic value of AIF-1 in pancreatic cancer; a recent study [51] revealed that AIF-1 acts as a robust diagnostic and prognostic biomarker in several types of cancer and is closely correlated with tumor immune infiltration. The gene discussed is AIF1; the disease is familial pancreatic carcinoma.